Silver acts at the scale of a cell
Silver can harm bacteria through ions, silver atoms carrying an electrical charge. These can interfere with the membranes that help bacterial cells control their internal conditions.
In a 2018 laboratory study, researchers tested very small silver particles against two bacterial species. Silver ions released from the particles disrupted the cells’ membrane function, caused potassium to leak out and reduced cellular respiration, part of the process of obtaining usable energy. The result helps explain how a particular silver material acts against bacteria; it is not a test of whether patients recover faster.
The dressing has more than one job
AQUACEL Ag provides a real medical example. Its 2007 FDA clearance covers specified wound-management uses. The documentation assigns microbial protection to its ionic silver, while the dressing’s gelling fibers absorb and retain wound fluid.
That distinction matters: the complete product combines different materials with different jobs. FDA clearance through the 510(k) process involves comparison with an already marketed device. It does not establish that silver makes every dressing better, or that all wounds heal faster with it. Product formulation, instructions and the condition being treated still matter.
A medical material is not a home remedy
A laboratory result does not make every silver coin or spoon a disinfectant, nor prove protection against viruses or fungi.
Colloidal silver consists of tiny silver particles in liquid. NIH’s NCCIH reports the FDA’s warning that it is not safe or effective for treating disease. It can cause argyria, a usually permanent blue-gray discoloration of the skin. Do not substitute it, homemade preparations or silver objects for medical care.
About this edition
Original source and editorial notes
Adapted from original material by Rich Silver. Original source card: Silver fact: supplied original card (publication date not established); Silver fact: supplied revised card (publication date not established).
Reviewed 2026-11-05. Reframed naturally antibacterial as a formulation-dependent property. Removed unsupported NASA, virus, historical milk-preservation, water-purification, and broad surface-protection claims. Distinguished a specific FDA-cleared dressing from clinical superiority or a general cure. Preserved both source records without reproducing their graphics. No card publication date or public URL is verified or inferred. General scientific information, not individual medical advice. Reader-first revision: Opens with charged silver ions and the tested bacterial membrane mechanism, then a named dressing’s distinct material roles. Defines ions, respiration, colloidal silver and argyria. Retains laboratory/patient-outcome distinction, formulation limits, product-specific FDA clearance and visible ingestion/home-remedy caution. No generic virus/fungus, NASA, milk-storage or all-silver-surface protection claim restored.
Sources & further reading
- Bondarenko and colleagues: Plasma membrane is the target of rapid antibacterial action of silver nanoparticles (2018), primary laboratory study ↗
- FDA: AQUACEL and AQUACEL Ag, K063271 clearance and product-specific indications (2007) ↗
- FDA: Medical Device Safety and the 510(k) Clearance Process ↗
- NIH NCCIH: Colloidal Silver, What You Need To Know ↗